glp 1 and longevity Overexpressing NHR-80 extends the lifespan of glp-1(e2141ts) mutants, Will the GLP-1 drugs promote
Description
doi:10.1126/scitranslmed.aan0972 13
The prevalence of AD is 10% in people over 65 years of age and 40% in people over 85 years of age
Regular follow-up allows identification and correction of application errors, supporting treatment adherence and optimal clinical outcomes
Below is an approximation of this videos audio content
Beyond its metabolic effects, GLP-1 exerts anti-inflammatory effects via several molecular pathways
